Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Total Liabilities (2020 - 2025)

Historic Total Liabilities for MDxHealth (MDXH) over the last 6 years, with Q3 2025 value amounting to $162.5 million.

  • MDxHealth's Total Liabilities rose 1575.91% to $162.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $162.5 million, marking a year-over-year increase of 1575.91%. This contributed to the annual value of $142.5 million for FY2024, which is 1686.62% up from last year.
  • As of Q3 2025, MDxHealth's Total Liabilities stood at $162.5 million, which was up 1575.91% from $160507.0 recorded in Q2 2025.
  • MDxHealth's Total Liabilities' 5-year high stood at $168.9 million during Q1 2025, with a 5-year trough of $160507.0 in Q2 2025.
  • In the last 5 years, MDxHealth's Total Liabilities had a median value of $119.9 million in 2023 and averaged $111.5 million.
  • Per our database at Business Quant, MDxHealth's Total Liabilities surged by 28980.58% in 2022 and then crashed by 9988.51% in 2025.
  • Quarter analysis of 5 years shows MDxHealth's Total Liabilities stood at $28.2 million in 2021, then surged by 289.81% to $109.8 million in 2022, then grew by 11.02% to $121.9 million in 2023, then rose by 16.87% to $142.5 million in 2024, then increased by 14.07% to $162.5 million in 2025.
  • Its Total Liabilities stands at $162.5 million for Q3 2025, versus $160507.0 for Q2 2025 and $168.9 million for Q1 2025.